Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: REPL stock price vs LYV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LYV's multiple
Needs Revenue / share, LYV P/S.
Implied fair value · at REPL's multiple
Needs REPL P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: REPL FY 2026 (ended Mar 31, 2026) · LYV FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
REPLIMUNE GROUP, INC. · implied price per share
Cash flow and years must be positive.
LIVE NATION ENTERTAINMENT, INC. · implied price per share
Bear
$20.64
Base
$24.28
Bull
$27.92
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.50x
28.09x
Net debt / EBITDA
Leverage against operating earnings
0.60x
0.27x
Cash and equivalents
Liquid reserves on the balance sheet
$268.89M
$7.09B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
REPL vs AMGN
INCYTE CORP
REPL vs INCY
Blueprint Medicines Corp
REPL vs BPMC
Adaptive Biotechnologies Corp
REPL vs ADPT
Endeavor Group Holdings, Inc.
REPL vs EDR
COMCAST CORP
REPL vs CMCSA
Walt Disney Co
REPL vs DIS
Six Flags Entertainment Corporation/NEW
REPL vs FUN
NETFLIX INC
REPL vs NFLX
$83.31M
$7.61B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe REPL can materially improve operating quality and eventually convert its loss-making profile into durable revenue and margin generation, then a cautious hold or selective add may make sense because the stock is currently trading inside its historical band and the provided data do not support a clean valuation discount case.
LYV-implied value of $2,907.56 is not directly actionable here because the comparison relies on LYV’s revenue-based valuation framework while REPL has N/A revenue and no P/S-derived implied price. REPL’s current price of $11.58 sits inside its historical band of $10.42 to $12.74, suggesting the market is pricing it near the middle of its recent range rather than at a clear distress or breakout level.
Supporting Metrics
